Evidence map›Paper›PMID 21291912›Full record

ArticleJournal of neuroscience methods2011

Ex vivo identification of protein-protein interactions involving the dopamine transporter.

Gregory C Hadlock, Chad C Nelson, Anthony J Baucum, Glen R Hanson, Annette E Fleckenstein

Abstract read
In one paragraph

Article in Journal of neuroscience methods, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.5field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Modafinil, an atypical CNS stimulant?Advances in pharmacology (San Diego, Calif.) · 2024
    Article
  3. Article
  4. Article
  5. Heteromeric Solute Carriers: Function, Structure, Pathology and Pharmacology.Advances in experimental medicine and biology · 2021
    Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Gregory C HadlockDepartment of Pharmacology and Toxicology, University of Utah, Skaggs Hall, 30 South 2000 East, Room 201, Salt Lake City, UT 84121, USA. gregory.hadlock@hsc.utah.edu
Chad C Nelson
Anthony J Baucum
Glen R Hanson
Annette E Fleckenstein
University of Utah · USUniversity of Montana · US

Funding

Vmat AND NEUROTOXICITYP01DA013367 · NIDA · UNIVERSITY OF UTAH · PI HANSON, GLEN R · 2001 to 2012
$10.1M
DRUG ABUSE &REGULATORY ENZYMES OF BIOGENIC AMINESR01DA000869 · NIDA · UNIVERSITY OF UTAH · PI FLECKENSTEIN, ANNETTE · 1985 to 2010
$2.9M
Psychostimulants and Monoamine TransportersR01DA011389 · NIDA · UNIVERSITY OF UTAH · PI FLECKENSTEIN, ANNETTE · 2003 to 2012
$2.5M
NEUROTENSIN AND METHAMPHETAMINE EFFECTSR01DA009407 · NIDA · UNIVERSITY OF UTAH · PI HANSON, GLEN R · 1995 to 2007
$2.2M
NEUROCHEMICAL ALTERATIONS BY DESIGNER DRUGSR01DA004222 · NIDA · UNIVERSITY OF UTAH · PI HANSON, GLEN R · 1986 to 2010
$2.0M
K02 ApplicationK02DA019447 · NIDA · UNIVERSITY OF UTAH · PI FLECKENSTEIN, ANNETTE · 2005 to 2014
$1.3M
Pharmacology and Toxicology of Methamphetamine Abuse (K05 DA00378)K05DA000378 · NIDA · UNIVERSITY OF UTAH · PI HANSON, GLEN R · 1998 to 2011
$1.2M
NIDA NIH HHS K02 DA019447NIDA NIH HHS K05 DA000378NIDA NIH HHS P01 DA013367NIDA NIH HHS R01 DA000869NIDA NIH HHS R01 DA004222NIDA NIH HHS R01 DA009407NIDA NIH HHS R01 DA011389
6 · The paper itself

Abstract

The dopamine (DA) transporter (DAT) is a key regulator of dopaminergic signaling as it mediates the reuptake of extrasynaptic DA and thereby terminates dopaminergic signaling. Emerging evidence indicates that DAT function is influenced through interactions with other proteins. The current report describes a method to identify such interactions following DAT immunoprecipitation from a rat striatal synaptosomal preparation. This subcellular fraction was selected since DAT function is often determined ex vivo by measuring DA uptake in this preparation and few reports investigating DAT-protein interactions have utilized this preparation. Following SDS-PAGE and colloidal Coomassie staining, selected protein bands from a DAT-immunoprecipitate were excised, digested with trypsin, extracted, and analyzed by liquid chromatography tandem mass spectrometry (LC/MS/MS). From the analysis of the tryptic peptides, several proteins were identified including DAT, Ca(2+)/calmodulin-dependent protein kinase II (CaMKII) β, CaMKII δ, protein kinase C (PKC) β, and PKC γ. Co-immunoprecipitation of PKC, CaMKII, and protein interacting with C kinase-1 with DAT was confirmed by Western blotting. Thus, the present study highlights a method to immunoprecipitate DAT and to identify co-immunoprecipitating proteins using LC/MS/MS and Western blotting. This method can be utilized to evaluate DAT protein-protein interactions but also to assess interactions involving other synaptic proteins. Ex vivo identification of protein-protein interactions will provide new insight into the function and regulation of a variety of synaptic, membrane-associated proteins, including DAT.

Indexed as

AnimalsBrain ChemistryDopamine Plasma Membrane Transport ProteinsMaleNerve Tissue ProteinsNeurochemistryPresynaptic TerminalsProtein Interaction MappingProteomicsRatsRats, Sprague-DawleySynaptosomesDopamine Plasma Membrane Transport ProteinsNerve Tissue Proteins

Identifiers

PMID21291912
PMCPMC3973427
OpenAlexW2057059028

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.